Avellino Labs Selected as Technology Pioneer

Share

Avellino Labs, a company providing eye care for good cost of laser eye surgery in Glasgow, announced that it is one of the 49 companies recognized by the World Economic Forum as a 2015 Technology Pioneer.

The technology pioneers were selected from applicants that were screened by a panel composed of 68 academics, businessmen, and corporate heads. Other companies selected in the past years include Google, Mozilla, and Dropbox.

Avellino Labs is the first and only developer of commercial testing system for DNA Test for Lasik and Refractive Surgery Safety, for Granular Corneal Dystrophy type 1 and type 2 (GCD1 and GCD2), which is also known as the Avellino Corneal Dystrophy. The company provides safe testing systems for a person’s genetic makeup concerning GCD1 and GCD2. This enables them to be able to accurately identify the GCD status of the patient. The test also enables the patient and doctor alike to make an informed decision prior to undergoing laser eye surgery.

Gene Lee, chairman and founder of Aveillino Labs, broke the news. He said that they were honored to be recognized especially in such a short amount of time since it was only in 2008 when they sought out to develop technologies that would be able to deliver affordable yet accurate genetic test for eye care.

Fulvia Montresor, Head of Technology Pioneers at the World Economic Forum, said that Avellino made it to the group for being one of the companies that was able to see a challenge in the world and was determined to do everything on their part to solve such problem.

The selection allows Avellino Labs to be linked to hundreds of networks worldwide. The company is also invited to the Summer Davos to be held by the World Economic Forum in Dalian, China in September.

Sang Yup Lee PhD, Professor at the Department of Chemical and Biomolecular Engineering, KAIST in Daejeon, South Korea, said that Avellino Labs was able to develop the technology needed to detect gene mutations in the cornea, which resulted into the protection of the visions of many patients who sought laser eye correction.

John Marshall, PhD FMedSci, Director of The Institute of Ophthalmology Eye Hospital, London expressed his delight by saying that Avellino Labs is the pioneer in eye DNA testing and was able to lead the industry in setting an example into a more personalized health and medical care for the eye.